Sponsor pipeline

Acepodia Biotech, Inc. clinical trial pipeline

Get alerts when Acepodia Biotech, Inc.'s trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-10-16

What changed in the last 30 days

1 trial changed in the last 30 days: 0 stopped, 1 with a notable change, 0 with minor changes only.

  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.

New trial filings, last 30 days

First postedTrialPhaseStatus
2026-10-06 NCT07861425 Phase 1 Trial of ACE723, A Dual-Payload Antibody Drug Conjugate, in Patients With… Phase 1 Not Yet Recruiting

Active trials by phase

Phase 1
2
Phase 1/2
1

Active trials

NCT IDTitleConditionStatusUpdated
Phase 1/2
NCT07061938 Study to Assess Safety, Efficacy and Persistence of ACE1831, in Subjects With… IgG4 Related Disease Recruiting 2026-10-02
Phase 1
NCT06415487 ACE2016 in Adult Subjects With Locally Advanced or Metastatic Solid Tumors Expressing… Locally Advanced Solid Tumor Recruiting 2025-07-01
NCT07861425 Phase 1 Trial of ACE723, A Dual-Payload Antibody Drug Conjugate, in Patients With… Hepatocellular Carcinoma (HCC) Not Yet Recruiting 2026-10-06

Disease areas by active trials

Liver Cancer (1)

Get alerts when Acepodia Biotech, Inc.'s trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free